Balyasny Asset Management’s Monster Beverage MNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Sell
17,318
-1,793,133
-99% -$141M ﹤0.01% 1985
2025
Q4
$139M Sell
1,810,451
-1,430,260
-44% -$102M 0.18% 120
2025
Q3
$218M Buy
3,240,711
+1,943,011
+150% +$121M 0.28% 57
2025
Q2
$81.3M Sell
1,297,700
-2,989,083
-70% -$183M 0.12% 198
2025
Q1
$251M Buy
4,286,783
+3,989,639
+1,343% +$208M 0.41% 30
2024
Q4
$15.6M Buy
297,144
+28,739
+11% +$1.52M 0.02% 769
2024
Q3
$14M Buy
268,405
+253,341
+1,682% +$12.6M 0.02% 789
2024
Q2
$752K Sell
15,064
-41,913
-74% -$2.22M ﹤0.01% 1899
2024
Q1
$3.38M Sell
56,977
-169,349
-75% -$9.73M 0.01% 1365
2023
Q4
$13M Sell
226,326
-227,044
-50% -$12.1M 0.02% 765
2023
Q3
$24M Buy
453,370
+432,065
+2,028% +$24.6M 0.05% 511
2023
Q2
$1.22M Sell
21,305
-51,600
-71% -$2.93M ﹤0.01% 1539
2023
Q1
$3.94M Sell
72,905
-1,254,129
-95% -$64.3M 0.01% 1173
2022
Q4
$67.4M Sell
1,327,034
-699,346
-35% -$33.9M 0.18% 133
2022
Q3
$88.1M Buy
+2,026,380
New +$93.4M 0.27% 71
2022
Q2
Sell
-281,710
Closed -$11.3M 3007
2022
Q1
$11.3M Sell
281,710
-752,670
-73% -$31.6M 0.04% 655
2021
Q4
$49.7M Buy
+1,034,380
New +$46M 0.17% 135
2021
Q2
Sell
-1,167,222
Closed -$53.2M 2197
2021
Q1
$53.2M Sell
1,167,222
-285,040
-20% -$12.8M 0.26% 81
2020
Q4
$67.2M Buy
1,452,262
+712,810
+96% +$29.9M 0.37% 49
2020
Q3
$29.7M Buy
739,452
+384,346
+108% +$15.2M 0.22% 122
2020
Q2
$12.3M Buy
+355,106
New +$11.6M 0.11% 293
2020
Q1
Sell
-1,174,206
Closed -$37.3M 1387
2019
Q4
$37.3M Buy
1,174,206
+248,190
+27% +$7.29M 0.22% 127
2019
Q3
$26.9M Sell
926,016
-210,492
-19% -$6.38M 0.18% 168
2019
Q2
$36.3M Buy
1,136,508
+1,006,134
+772% +$30.3M 0.23% 105
2019
Q1
$3.56M Buy
130,374
+51,056
+64% +$1.46M 0.02% 652
2018
Q4
$1.95M Buy
79,318
+12,332
+18% +$335K 0.01% 722
2018
Q3
$1.95M Sell
66,986
-512,424
-88% -$15.4M 0.01% 984
2018
Q2
$16.6M Buy
+579,410
New +$15.6M 0.08% 354
2018
Q1
Sell
-49,200
Closed -$1.56M 2183
2017
Q4
$1.56M Buy
+49,200
New +$1.47M ﹤0.01% 1218
2017
Q3
Sell
-853,184
Closed -$21.2M 2015
2017
Q2
$21.2M Sell
853,184
-1,340,148
-61% -$32.3M 0.09% 304
2017
Q1
$50.6M Buy
2,193,332
+95,116
+5% +$2.13M 0.24% 108
2016
Q4
$46.5M Sell
2,098,216
-582,878
-22% -$13.3M 0.25% 104
2016
Q3
$65.6M Buy
2,681,094
+2,232,864
+498% +$58M 0.38% 67
2016
Q2
$12M Sell
448,230
-4,759,746
-91% -$115M 0.08% 314
2016
Q1
$116M Buy
5,207,976
+4,487,802
+623% +$100M 0.69% 17
2015
Q4
$17.9M Buy
720,174
+579,216
+411% +$14M 0.12% 228
2015
Q3
$3.17M Sell
140,958
-1,099,080
-89% -$25.8M 0.02% 601
2015
Q2
$27.7M Buy
+1,240,038
New +$27.7M 0.17% 156
2014
Q3
Sell
-922,800
Closed -$10.9M 806
2014
Q2
$10.9M Buy
+922,800
New +$10.5M 0.12% 214
2014
Q1
Sell
-1,370,568
Closed -$15.5M 624
2013
Q4
$15.5M Buy
1,370,568
+164,946
+14% +$1.62M 0.2% 131
2013
Q3
$10.5M Buy
1,205,622
+673,386
+127% +$6.64M 0.14% 192
2013
Q2
$5.4M Buy
+532,236
New +$5M 0.09% 270

Other funds holding MNST

Balyasny Asset Management's MNST Position: Q1 2026 in Review

Balyasny Asset Management reduced its Monster Beverage (MNST) stake by 99% in Q1 2026, selling an estimated $141M and leaving 17,318 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1985.

Balyasny Asset Management first reported a position in MNST in Q2 2013 and has held it in 42 quarters since. The position peaked at $251M in Q1 2025. 1,236 funds tracked by Wall St. Rank hold MNST as of Q1 2026.

  • Balyasny Asset Management held 17,318 shares of Monster Beverage worth $1.25M as of Q1 2026.
  • Balyasny Asset Management sold 1,793,133 Monster Beverage shares in Q1 2026, an estimated $141M.
  • Monster Beverage made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1985 holding.
  • Balyasny Asset Management first reported a position in Monster Beverage in Q2 2013 and has held it in 42 quarters since.
  • Balyasny Asset Management's Monster Beverage position peaked at $251M in Q1 2025.
  • 1,236 funds tracked by Wall St. Rank held Monster Beverage as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.